Renovorx Stock Retained Earnings

RNXT Stock

USD 1.21 0.02 1.68%

RenovoRx fundamentals help investors to digest information that contributes to RenovoRx's financial success or failures. It also enables traders to predict the movement of RenovoRx Stock. The fundamental analysis module provides a way to measure RenovoRx's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to RenovoRx stock.

		Last Reported	Projected for Next Year
	Retained Earnings	-41.4 M	-39.3 M

Retained Earnings is likely to gain to about (39.3 M) in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

RenovoRx Company Retained Earnings Analysis

RenovoRx's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.

Retained Earnings

Beginning RE + Income

-

Dividends

More About Retained Earnings | All Equity Analysis

Current RenovoRx Retained Earnings

(41.41 M)

Most of RenovoRx's fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RenovoRx is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

RenovoRx Retained Earnings Driver Correlations

Understanding the fundamental principles of building solid financial models for RenovoRx is extremely important. It helps to project a fair market value of RenovoRx Stock properly, considering its historical fundamentals such as Retained Earnings. Since RenovoRx's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of RenovoRx's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of RenovoRx's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Common Stock	Current Deferred Revenue	Long Term Debt	Short Long Term Debt	Short Term Debt	Property Plant Equipment
Total Assets		0.88	0.62	-0.78	-0.15	0.07	-0.67	0.88	1.0	0.2	0.98	0.2	0.2	0.2	0.2	0.2	0.2
Total Stockholder Equity	0.88		0.91	-0.91	-0.58	0.22	-0.94	1.0	0.88	-0.2	0.88	-0.2	-0.2	-0.2	-0.2	-0.2	-0.2
Net Tangible Assets	0.62	0.91		-0.88	-0.85	0.22	-0.97	0.9	0.62	-0.57	0.62	-0.57	-0.57	-0.57	-0.57	-0.57	-0.57
Net Debt	-0.78	-0.91	-0.88		0.68	0.18	0.86	-0.94	-0.78	0.31	-0.69	0.31	0.31	0.31	0.31	0.31	0.31
Retained Earnings	-0.15	-0.58	-0.85	0.68		-0.05	0.79	-0.59	-0.15	0.8	-0.12	0.8	0.8	0.8	0.8	0.8	0.8
Accounts Payable	0.07	0.22	0.22	0.18	-0.05		-0.3	0.13	0.07	-0.06	0.28	-0.06	-0.06	-0.06	-0.06	-0.06	-0.06
Total Liab	-0.67	-0.94	-0.97	0.86	0.79	-0.3		-0.93	-0.67	0.41	-0.68	0.41	0.41	0.41	0.41	0.41	0.41
Net Invested Capital	0.88	1.0	0.9	-0.94	-0.59	0.13	-0.93		0.88	-0.2	0.86	-0.2	-0.2	-0.2	-0.2	-0.2	-0.2
Total Current Assets	1.0	0.88	0.62	-0.78	-0.15	0.07	-0.67	0.88		0.2	0.98	0.2	0.2	0.2	0.2	0.2	0.2
Capital Stock	0.2	-0.2	-0.57	0.31	0.8	-0.06	0.41	-0.2	0.2		0.19	1.0	1.0	1.0	1.0	1.0	1.0
Net Working Capital	0.98	0.88	0.62	-0.69	-0.12	0.28	-0.68	0.86	0.98	0.19		0.19	0.19	0.19	0.19	0.19	0.19
Common Stock	0.2	-0.2	-0.57	0.31	0.8	-0.06	0.41	-0.2	0.2	1.0	0.19		1.0	1.0	1.0	1.0	1.0
Current Deferred Revenue	0.2	-0.2	-0.57	0.31	0.8	-0.06	0.41	-0.2	0.2	1.0	0.19	1.0		1.0	1.0	1.0	1.0
Long Term Debt	0.2	-0.2	-0.57	0.31	0.8	-0.06	0.41	-0.2	0.2	1.0	0.19	1.0	1.0		1.0	1.0	1.0
Short Long Term Debt	0.2	-0.2	-0.57	0.31	0.8	-0.06	0.41	-0.2	0.2	1.0	0.19	1.0	1.0	1.0		1.0	1.0
Short Term Debt	0.2	-0.2	-0.57	0.31	0.8	-0.06	0.41	-0.2	0.2	1.0	0.19	1.0	1.0	1.0	1.0		1.0
Property Plant Equipment	0.2	-0.2	-0.57	0.31	0.8	-0.06	0.41	-0.2	0.2	1.0	0.19	1.0	1.0	1.0	1.0	1.0

Click cells to compare fundamentals

Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.

Competition

Predict RenovoRx

Retained Earnings Over Time

Based on the latest financial disclosure, RenovoRx has a Retained Earnings of (41.41 Million). This is 104.45% lower than that of the Biotechnology sector and 142.73% lower than that of the Health Care industry. The retained earnings for all United States stocks is 100.44% higher than that of the company.

RenovoRx Retained Earnings Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RenovoRx's direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of RenovoRx could also be used in its relative valuation, which is a method of valuing RenovoRx by comparing valuation metrics of similar companies.

RenovoRx is currently under evaluation in retained earnings category among its peers.

RenovoRx Fundamentals

	Return On Equity	-1.55
	Return On Asset	-0.7
	Current Valuation	19 M
	Shares Outstanding	24 M
	Shares Owned By Insiders	1.90 %
	Shares Owned By Institutions	8.18 %
	Number Of Shares Shorted	71.85 K
	Price To Book	4.04 X
	EBITDA	(11.39 M)
	Net Income	(10.23 M)
	Cash And Equivalents	10.77 M
	Cash Per Share	1.19 X
	Total Debt	4.47 M
	Current Ratio	10.01 X
	Book Value Per Share	(0.28) X
	Cash Flow From Operations	(10.26 M)
	Short Ratio	3.43 X
	Earnings Per Share	(0.58) X
	Target Price	5.25
	Beta	0.99
	Market Capitalization	28.56 M
	Total Asset	1.47 M
	Retained Earnings	(41.41 M)
	Working Capital	291 K
	Net Asset	1.47 M

About RenovoRx Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze RenovoRx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RenovoRx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RenovoRx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for RenovoRx Stock Analysis

When running RenovoRx's price analysis, check to measure RenovoRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovoRx is operating at the current time. Most of RenovoRx's value examination focuses on studying past and present price action to predict the probability of RenovoRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovoRx's price. Additionally, you may evaluate how the addition of RenovoRx to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC